As a pioneering company addressing the microbiome to understand health and disease, MetaboGen is creating breakthrough opportunities to develop novel therapeutics and next generation probiotics. The company was founded based on world leading science from the labs of Professor Fredrik Bäckhed and Professor Jens B Nielsen, to provide commercial access to metagenome research and development. MetaboGen has built a platform that integrates top-of-the line metagenomic data analysis with strain identification and subsequent development as well as clinical programs, to ensure successful development of novel assets.